C-GUD

T:GUD - KNIGHT THERAPEUTICS INC. - http://www.gud-knight.com

23:56:47 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
GUD - T	0.2	5.74	·	5.85	1.8	5.77			25.3	137	141	5.73 5.81 5.70	5.95 4.35	16:00:00	Apr 09	15 min RT 2¢
TSX - T	0.2	5.74	·	5.85	1.8	5.77			12.0	65	69	5.73 5.80 5.71	5.95 4.35	16:00:00		15 min
NEO ATS - U						5.80	+0.03	0.5	5.1	28	17	5.72 5.81 5.70		15:33:01		15 min
Alpha - A						5.77			2.6	15	3	5.80 5.80 5.73		15:59:31		15 min
Omega - O						5.78	+0.01	0.2	2.2	11	22	5.72 5.78 5.71		15:32:16		15 min
Pure - P						5.77			0.01		2			Apr 29		15 min
Chi-X - X						5.80	+0.03	0.5	2.0	11	14	5.75 5.80 5.70		15:14:07		15 min
CX2 - H						5.77			0.6	3	5	5.70 5.77 5.70		15:59:59		15 min
CXD - D						5.77			0.1	1	2			Apr 30		15 min
TriAct - M						5.77			0.7	4	7			Sep 11-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Show ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 141

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
16:00:00	T	5.77		100	13 Instinet	53 Morgan Stanley	KQ
16:00:00	T	5.77		100	1 Anonymous	1 Anonymous	KQ
16:00:00	T	5.77		35	5 Citadel	1 Anonymous	Q
16:00:00	T	5.77		1	5 Citadel	1 Anonymous	Q
16:00:00	T	5.77		44	1 Anonymous	5 Citadel	Q
16:00:00	T	5.77		92	5 Citadel	1 Anonymous	Q
15:59:59	H	5.77		100	1 Anonymous	79 CIBC	K
15:59:31	A	5.77		500	79 CIBC	1 Anonymous	K
15:48:05	T	5.77		100	79 CIBC	53 Morgan Stanley	K
15:33:01	U	5.80	0.03	100	13 Instinet	79 CIBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-03-27 08:10	C:GUD	5.44	SEDAR Annual Report803	SEDAR Annual Report
2024-03-22 07:58	C:GUD	5.27	In the News525	Globe says Knight seen "as a good long-term investment"
2024-03-21 13:42	C:GUD	5.23	SEDAR MD & A815	SEDAR MD & A
2024-03-21 10:45	C:GUD	5.39	News Release200	Knight Therapeutics loses $16.83-million in 2023
2024-03-21 07:50	C:GUD	5.39	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-03-21 07:50	C:GUD	5.39	SEDAR MD & A815	SEDAR MD & A
2024-03-21 07:45	C:GUD	5.39	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-03-14 08:26	C:GUD	5.28	News Release200	Knight Therapeutics to release 2023 results March 21
2024-03-07 07:52	C:GUD	5.51	In the News525	Globe says Knight Therapeutics kept at "outperform"
2024-02-29 12:43	C:GUD	5.55	News Release200	Knight Therapeutics rolls out Minjuvi in Brazil
2024-02-21 17:53	C:GUD	5.41	News Release200	Knight applies for fostamatinib marketing nod in Brazil
2024-02-06 11:27	C:GUD		News Release200	Knight Therapeutics rolls out Bijuva capsules in Canada
2024-01-25 10:34	C:GUD	5.51	News Release200	Knight Therapeutics licenses IPX203 from Amneal
2024-01-04 10:31	C:GUD	5.36	News Release200	Knight Therapeutics rolls out IMVEXXY in Canada
2023-12-19 10:49	C:GUD	5.15	News Release200	Knight Therapeutics licenses Qelbree from Supernus
2023-11-09 13:48	C:GUD	4.78	News Release200	Knight Therapeutics earns $9.58-million in Q3
2023-11-09 10:05	C:GUD	4.78	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-11-09 10:05	C:GUD	4.78	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-11-02 13:39	C:GUD	4.61	News Release200	Knight Therapeutics to release Q3 2023 results Nov. 9
2023-10-16 10:29	C:GUD	4.65	News Release200	Knight to roll out Minjuvi in Brazil in Q2 2024